CoChat

Treatment of endometriosis with the antiprogesterone mifepristone (RU486)

Open access
Michael Kettel, L., Murphy, Ana A., Morales, Arlene J., Ulmann, André, Baulieu, Etienne E., Yen, Samuel S.C. · 1996 · Fertility and Sterility

The DOI matches its Crossref record; 24 of the 28 references it cites were found in a registry or an index.

Abstract

Objective To evaluate the safety and efficacy of an antiprogesterone (mifepristone, RU486; Roussel-Uclaf, Romaineville, France) on endometriosis.Design An open, prospective clinical trial.Setting The clinical practice of an academic faculty.Patients Nine women with endometriosis were studied.Interventions RU486 (50 mg/d) was administered for 6 months.Main outcome measures Daily symptom inventories and urinary steroid metabolites were assessed before, during, and after treatment. Blood for hormone analysis was obtained weekly for 4 weeks and monthly thereafter. The extent of endometriosis, bone mineral density, circadian rhythm of cortisol, and LH pulsatility were determined before and after treatment. Safety laboratory measurements were made before and at 1, 2, and 6 months of treatment.Results Pelvic pain and uterine cramping improved in all patients. Endometriosis regressed by 55%. All patients exhibited endocrine features of anovulatory amenorrhea without hypoestrogenism. A rise in serum LH and T levels was observed during the first month of treatment and one patient developed an elevation of liver transaminases during the last month of treatment. All other measurements were unchanged.Conclusion RU486 appears to be effective in improving the symptoms and causing regression of endometriosis in the absence of significant side effects.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(16)58022-4

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 1

  1. Veldhuis, 1988, A novel general biophysical model for simulating episodic endocrine signaling, Am J Physiol, 255, E749

Cited by

See all 220

Metadata

Authors
Michael Kettel, L., Murphy, A. A., Morales, A. J., Ulmann, A., Baulieu, E. E., & Yen, S. S. C.
Affiliations
Université Paris-Sud (FR)
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
1996-01
Volume
65
Issue
1
Pages
23-28
ISSN
0015-0282 (ISSN-L)
OpenAlex
W1910306760
Cited by
216
References
28
Citations by year
2026: 3 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 10 · 2020: 3 · 2019: 9 · 2018: 12 · 2017: 5 · 2016: 10 · 2015: 9 · 2014: 8 · 2013: 8 · 2012: 8
FWCI
7.44
Type
journal article
Language
en
Open access
Licence
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Center for Research Resources (M-01RR00827, M01RR000827)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, mifepristone, RU486, pelvic pain, luteinizing hormone, testosterone, bone mineral density, diurnal cortisol rhythm, liver transaminases, drug safety
MeSH terms
Adolescent, Adult, Endometriosis, Estrone, Female, Hormone Antagonists, Humans, Luteinizing Hormone, Progesterone, Prospective Studies, Mifepristone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of endometriosis with the antiprogesterone mifepristone (RU486). https://app.cochat.ai/papers/10.1016/s0015-0282(16)58022-4
The paper
Michael Kettel, L., Murphy, A. A., Morales, A. J., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1996). Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertility and Sterility. https://doi.org/10.1016/s0015-0282(16)58022-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.